Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
基本信息
- 批准号:8743195
- 负责人:
- 金额:$ 62.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-30 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAftercareBehavior monitoringBehavioral SciencesBlindedBreastCancer Control ResearchCancer PatientCancer SurvivorCancer SurvivorshipCaringCase ManagerChronic DiseaseChronically IllCollaborationsColorectalComplexComputer softwareControl GroupsDataDevelopmentDisease ManagementEducationEnrollmentEnsureEthnographyEvaluationFocus GroupsGoalsGrowthHealthHealth CommunicationHealth PersonnelHealth behaviorHealthcareIndividualInstitute of Medicine (U.S.)Interdisciplinary StudyInternetInterventionInterviewLate EffectsLong-Term SurvivorsMalignant NeoplasmsMediator of activation proteinMedicalMedical Care TeamMonitorMonitoring for RecurrenceMultimediaNew JerseyOnline SystemsOutcomeParticipantPatient CarePatientsPhasePhysiciansPopulationPremature aging syndromePreventivePreventive Health ServicesPrimary Health CarePrintingProcessProstateProviderQualitative MethodsRandomized Controlled TrialsRecruitment ActivityRecurrenceRegimenReportingResearchResearch DesignResearch PersonnelRiskScreening for cancerSelf CareSelf ManagementServicesSocial InteractionSocial SciencesStagingSurvivorsTechnologyTelephoneTelephone InterviewsTestingTranslationsUnited StatesWorkactive methodbasebehavioral/social sciencecancer educationcancer preventioncancer recurrencecancer therapycomputerized data processingcopingdesigndisorder preventiondissemination researchevidence baseexperiencefollow-upgroup interventionimplementation researchimprovedinnovationiterative designmembernoveloncologyprimary care settingprimary outcomeprogramspsychosocialresearch studysecondary outcomesurvivorshiptheoriestherapy developmenttooltreatment as usualuptakeusability
项目摘要
There are 13.7 million cancer survivors in the United States. By 2050 the rate of growth for cancer survivors is expected to outpace the rate of growth for incident cancer cases. Approximately 70 percent of cancer survivors have co-morbid conditions that require a comprehensive approach to their medical care. Yet, cancer survivors do not receive recommended follow-up care at appropriate levels, with regard to both needed preventive care and chronic disease management. Survivors may benefit from psychosocial tools and support to help them cope with care transitions, to appropriately monitor their health, and to help them manage their interactions with members of the healthcare provider team. Unfortunately, there is currently a lack of psychosocial tools designed specifically to help survivors proactively manage their healthcare from the termination of treatment into extended survivorship. To fill this void, we draw on the social and behavioral science evidence base in social interaction and health communication to develop and test a highly innovative, self-management intervention: Extended Cancer Education for Longer-term Survivors (EXCELS). Based on health communication best practices, as well as on smart technology for ready access to patients, the EXCELS intervention will consist of (1) enhanced education and decision support materials delivered via mobile web and smart phone application and (2) health coaching engagement. The plan for intervention development involves three steps: first, during the formative phase, we will use qualitative methods (i.e., focus groups with survivors, depth interviews with primary care healthcare team members, user testing) to inform the design and iterative development of EXCELS. Second, we will pilot the intervention using a randomized controlled trial study design. Specifically, we will enroll 480 cancer survivors (breast, prostate,
colorectal) who have completed active cancer treatment at least 2 years ago. The comprehensive EXCELS intervention consists of an ongoing 12 month intervention that entails (1) enhanced education and self-care support materials delivered via mobile web/smart phone application and (2) health coaching calls. A 2X2 factorial design will be used to test "proof of concept" or efficacy for the fully implemented EXCELS intervention compared with usual care so that the combined intervention - as well as each individual component - will be tested. The primary outcomes are use of preventive health services and tracking of cancer recurrence and late effects with patient coping as a secondary outcome. Outcomes will be assessed at baseline and at 6, 12, and 18 months by telephone interviews and chart audit by blinded research staff. Finally, a process evaluation of intervention implementation, as well as pilot data from this study, will be used to refine the intervention for testing in a larger implementation and dissemination research study.
美国有 1370 万癌症幸存者。到 2050 年,癌症幸存者的增长率预计将超过癌症病例的增长率。大约 70% 的癌症幸存者患有共病,需要采取全面的医疗护理方法。然而,在所需的预防性护理和慢性病管理方面,癌症幸存者没有得到建议的适当水平的后续护理。幸存者可能会受益于心理社会工具和支持,以帮助他们应对护理过渡,适当监测他们的健康状况,并帮助他们管理与医疗保健提供者团队成员的互动。不幸的是,目前缺乏专门设计来帮助幸存者主动管理从治疗终止到延长生存期的医疗保健的心理社会工具。为了填补这一空白,我们利用社交互动和健康沟通方面的社会和行为科学证据基础来开发和测试高度创新的自我管理干预措施:针对长期幸存者的扩展癌症教育 (EXCELS)。基于健康沟通最佳实践以及易于接触患者的智能技术,EXCELS 干预措施将包括 (1) 通过移动网络和智能手机应用程序提供的强化教育和决策支持材料以及 (2) 健康指导参与。干预开发计划包括三个步骤:首先,在形成阶段,我们将使用定性方法(即幸存者焦点小组、初级保健医疗团队成员深度访谈、用户测试)为 EXCELS 的设计和迭代开发提供信息。其次,我们将使用随机对照试验研究设计来试行干预措施。具体来说,我们将招募 480 名癌症幸存者(乳腺癌、前列腺癌、
结直肠癌)至少 2 年前已完成积极的癌症治疗。全面的 EXCELS 干预措施包括持续 12 个月的干预措施,其中包括 (1) 通过移动网络/智能手机应用程序提供强化教育和自我护理支持材料,以及 (2) 健康辅导电话。 2X2 因子设计将用于测试“概念验证”或与常规护理相比完全实施的 EXCELS 干预措施的功效,以便测试组合干预措施以及每个单独的组成部分。主要结局是预防性卫生服务的使用以及跟踪癌症复发和晚期影响,并将患者的应对情况作为次要结局。将通过双盲研究人员的电话访谈和图表审核在基线以及第 6、12 和 18 个月时评估结果。最后,干预措施实施的过程评估以及本研究的试点数据将用于完善干预措施,以便在更大规模的实施和传播研究中进行测试。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHAWNA V. HUDSON其他文献
SHAWNA V. HUDSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHAWNA V. HUDSON', 18)}}的其他基金
Reducing Urban Cervical Cancer Disparities Using a Tailored mHealth Intervention to Enhance Colposcopy Attendance
使用量身定制的移动医疗干预措施来减少城市宫颈癌的差异,以提高阴道镜检查的出勤率
- 批准号:
10659894 - 财政年份:2023
- 资助金额:
$ 62.67万 - 项目类别:
Re-entry Supplement to Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者 (EXCELS) 扩展癌症教育的重返补充
- 批准号:
8843650 - 财政年份:2013
- 资助金额:
$ 62.67万 - 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
- 批准号:
9379052 - 财政年份:2013
- 资助金额:
$ 62.67万 - 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
- 批准号:
9326812 - 财政年份:2013
- 资助金额:
$ 62.67万 - 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
- 批准号:
8917755 - 财政年份:2013
- 资助金额:
$ 62.67万 - 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
- 批准号:
8641008 - 财政年份:2013
- 资助金额:
$ 62.67万 - 项目类别:
Predictors of Follow-Up Care Seeking Among Breast and Prostate Cancer Survivors
乳腺癌和前列腺癌幸存者寻求后续护理的预测因素
- 批准号:
8700941 - 财政年份:2011
- 资助金额:
$ 62.67万 - 项目类别:
Predictors of Follow-Up Care Seeking Among Breast and Prostate Cancer Survivors
乳腺癌和前列腺癌幸存者寻求后续护理的预测因素
- 批准号:
8133263 - 财政年份:2011
- 资助金额:
$ 62.67万 - 项目类别:
Predictors of Follow-Up Care Seeking Among Breast and Prostate Cancer Survivors
乳腺癌和前列腺癌幸存者寻求后续护理的预测因素
- 批准号:
8230599 - 财政年份:2011
- 资助金额:
$ 62.67万 - 项目类别:
Life After Cancer: Examining Survivor Transitions From Specialist to Primary Care
癌症后的生活:检查幸存者从专科护理到初级护理的转变
- 批准号:
8700972 - 财政年份:2008
- 资助金额:
$ 62.67万 - 项目类别:
相似海外基金
Using in-vivo Real-time Biosensor to Evaluate Prodrugs Designed to Prolong Therapeutic Effects for Smoking Cessation.
使用体内实时生物传感器评估旨在延长戒烟治疗效果的前药。
- 批准号:
10546293 - 财政年份:2023
- 资助金额:
$ 62.67万 - 项目类别:
Stepped Care, Peer-Delivered Intervention to Improve ART Adherence and SUD in Primary Care
阶梯式护理、同伴提供的干预措施可提高初级护理中的 ART 依从性和 SUD
- 批准号:
10675089 - 财政年份:2022
- 资助金额:
$ 62.67万 - 项目类别:
Newborn screening and treatment monitoring for patients with pyridoxine-dependent epilepsy
吡哆醇依赖性癫痫患者的新生儿筛查和治疗监测
- 批准号:
10372396 - 财政年份:2022
- 资助金额:
$ 62.67万 - 项目类别:
Treating Polysubstance Use in Methadone Maintenance: Application of Novel Digital Technology
治疗美沙酮维持中的多物质使用:新型数字技术的应用
- 批准号:
10588517 - 财政年份:2022
- 资助金额:
$ 62.67万 - 项目类别: